End-of-life management in patients with amyotrophic lateral sclerosis

The Lancet Neurology

Volumn 14, Issue 4, 2015, Pages 435-442

  Connolly, Sheelah ^a   Galvin, Miriam ^b   Hardiman, Orla ^a,c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; ATTITUDE TO ILLNESS; CAREGIVER; CLINICAL PRACTICE; COGNITION; COMMUNICATION SKILL; DEATH; DECISION MAKING; DYING; ETHICS; EUTHANASIA; FAMILY; FATIGUE; FEAR; GASTROSTOMY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH PROMOTION; HUMAN; HUMAN DIGNITY; LEGAL ASPECT; LIVING WILL; LONG TERM CARE; MEDICAL EDUCATION; MENTAL CAPACITY; MENTAL STRESS; MORALITY; NEUROLOGIC DISEASE; NON INVASIVE PROCEDURE; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PATIENT AUTONOMY; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REASSURANCE; REVIEW; TERMINAL CARE; TERMINAL DISEASE; TREATMENT REFUSAL; ASSISTED SUICIDE; ATTITUDE TO DEATH; CLINICAL COMPETENCE; EDUCATION; EMPATHY; EPIDEMIOLOGY; ETIOLOGY; EUROPE; HOSPICE CARE; INTERPERSONAL COMMUNICATION; PERSONAL AUTONOMY; PREVENTION AND CONTROL; PSYCHOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

ADVANCE DIRECTIVES; AMYOTROPHIC LATERAL SCLEROSIS; ATTITUDE TO DEATH; CAREGIVERS; CLINICAL COMPETENCE; COGNITION; COMMUNICATION; DECISION MAKING; EDUCATION, MEDICAL; EMPATHY; EUROPE; HEALTH PERSONNEL; HOSPICE CARE; HUMANS; MENTAL COMPETENCY; PALLIATIVE CARE; PERSONAL AUTONOMY; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; SUICIDE, ASSISTED; TERMINAL CARE; UNITED STATES;

EID: 84926408758     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70221-2     Document Type: Review

References (96)

1. Simmons Z Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. Neurologist 2005, 11:257-270.
2. Rooney J, Byrne S, Heverin M, et al. Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. PLoS One 2013, 8:e74733.
3. Oliver D, Borasio GD, Voltz R, et al. The development of a consensus paper on palliative care in neurology: the implications for ALS care. Amyotroph Lateral Scler Frontotemporal Degener 2014, 15:117-118.
4. Bede P, Oliver D, Stodart J, et al. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry 2011, 82:413-418.
5. Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol 2012, 19:360-375. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis.
6. Veronese S, Oliver D Palliative care for people with neurodegenerative conditions 2013, Lambert Academic Publishing.
7. Boersma I, Miyasaki J, Kutner J, Kluger B Palliative care and neurology: time for a paradigm shift. Neurology 2014, 83:561-567.
8. O'Leary N, Tiernan E Survey of specialist palliative care services for noncancer patients in Ireland and perceived barriers. Palliat Med 2008, 22:77-83.
9. Ganzini L, Johnston WS, Silveira MJ The final month of life in patients with ALS. Neurology 2002, 59:428-431.
10. Mitsumoto H, Bromberg M, Johnston W, et al. Promoting excellence in end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:145-154.
11. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 1996, 313:29-33.
12. Fegg MJ, Kramer M, L'hoste S, Borasio GD The Schedule for Meaning in Life Evaluation (SMiLE): validation of a new instrument for meaning-in-life research. J Pain Symptom Manage 2008, 35:356-364.
13. Tramonti F, Bongioanni P, Di Bernardo C, Davitti S, Rossi B Quality of life of patients with amyotrophic lateral sclerosis. Psychol Health Med 2012, 17:621-628.
14. Olsson AG, Markhede I, Strang S, Persson LI Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin. Palliat Support Care 2010, 8:75-82.
15. Felgoise SH, Stewart JL, Bremer BA, Walsh SM, Bromberg MB, Simmons Z The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations. Amyotroph Lateral Scler 2009, 10:456-462.
16. Fegg MJ, Kögler M, Brandstätter M, et al. Meaning in life in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010, 11:469-474.
17. Oliver D, Campbell C, Sloan R, et al. End-of-life care and decision making in ALS/MND: A cross-cultural study. Amyotroph Lateral Scler 2007, 8:13-15.
18. Munroe CA, Sirdofsky MD, Kuru T, Anderson ED End-of-life decision making in 42 patients with amyotrophic lateral sclerosis. Respir Care 2007, 52:996-999.
19. Benditt JO, Smith TS, Tonelli MR Empowering the individual with ALS at the end-of-life: disease-specific advance care planning. Muscle Nerve 2001, 24:1706-1709.
20. Heritier Barras AC, Adler D, Iancu Ferfoglia R, et al. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group. Swiss Med Wkly 2013, 143:w13830. the CeSLA group.
21. Oliver DJ, Turner MR Some difficult decisions in ALS/MND. Amyotroph Lateral Scler 2010, 11:339-343.
22. Shaw J, Brown R, Heinrich P, Dunn S Doctors' experience of stress during simulated bad news consultations. Patient Educ Couns 2013, 93:203-208.
23. Shaw JM, Brown RF, Dunn SM A qualitative study of stress and coping responses in doctors breaking bad news. Patient Educ Couns 2013, 91:243-248.
24. Giordano J Respice...prospice: philosophy, ethics and medical care- past, present, and future. Philos Ethics Humanit Med 2010, 5:17.
25. Pereira J, Pautex S, Cantin B, et al. Palliative care education in Swiss undergraduate medical curricula: a case of too little, too early. Palliat Med 2008, 22:730-735.
26. Vail L, Sandhu H, Fisher J, Cooke H, Dale J, Barnett M Hospital consultants breaking bad news with simulated patients: an analysis of communication using the Roter Interaction Analysis System. Patient Educ Couns 2011, 83:185-194.
27. van Weel-Baumgarten EM, Brouwers M, Grosfeld F, Jongen Hermus F, Van Dalen J, Bonke B Teaching and training in breaking bad news at the Dutch medical schools: a comparison. Med Teach 2012, 34:373-381.
28. Merlin LR, Horak HA, Milligan TA, Kraakevik JA, Ali II A competency-based longitudinal core curriculum in medical neuroscience. Neurology 2014, 83:456-462.
29. Brown R, Dunn S, Byrnes K, Morris R, Heinrich P, Shaw J Doctors' stress responses and poor communication performance in simulated bad-news consultations. Acad Med 2009, 84:1595-1602.
30. Gama G, Barbosa F, Vieira M Personal determinants of nurses' burnout in end of life care. Eur J Oncol Nurs 2014, 18:527-533.
31. Rushton CH, Kaszniak AW, Halifax JS A framework for understanding moral distress among palliative care clinicians. J Palliat Med 2013, 16:1074-1079.
32. Rushton CH, Kaszniak AW, Halifax JS Addressing moral distress: application of a framework to palliative care practice. J Palliat Med 2013, 16:1080-1088.
33. Bowden J, Dempsey K, Boyd K, Fallon M, Murray SA Are newly qualified doctors prepared to provide supportive and end-of-life care? A survey of Foundation Year 1 doctors and consultants. J R Coll Physicians Edinb 2013, 43:24-28.
34. Kaub-Wittemer D, Steinbüchel N, Wasner M, Laier-Groeneveld G, Borasio GD Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage 2003, 26:890-896.
35. Roche JC, Rojas-Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012, 135:847-852.
36. Balendra R, Jones A, Jivraj N, et al. Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. J Neurol Neurosurg Psychiatry 2015, 86:45-49. the UK-MND LiCALS Study Group, Mito Target ALS Study GroupMito Target ALS Study Group.
37. Borasio GD, Shaw PJ, Hardiman O, Ludolph AC, Sales Luis ML, Silani V Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:159-164. the European ALS Study Group.
38. Veronese S, Valle A, Chio A, Calvo A, Oliver D The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener 2014, 15:499-504.
39. Rabkin J, Ogino M, Goetz R, et al. Tracheostomy with invasive ventilation for ALS patients: neurologists' roles in the US and Japan. Amyotroph Lateral Scler Frontotemporal Degener 2013, 14:116-123.
40. Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013, 80:1590-1597.
41. Neary D, Snowden J, Mann D Frontotemporal dementia. Lancet Neurol 2005, 4:771-780.
42. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012, 83:102-108.
43. Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 2015, 86:168-173.
44. Klein E, Karlawish J Ethical issues in the neurology of aging and cognitive decline. Handb Clin Neurol 2013, 118:233-242.
45. Abrahams S, Newton J, Niven E, Foley J, Bak TH Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014, 15:9-14.
46. van der Steen JT, van Soest-Poortvliet MC, Hallie-Heierman M, et al. Factors associated with initiation of advance care planning in dementia: a systematic review. J Alzheimers Dis 2014, 40:743-757.
47. Miller RG, Mitchell JD, Moore DH Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012, 3. CD001447.
48. Radunovic A, Annane D, Rafiq MK, Mustfa N Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2013, 3. CD004427.
49. Baxter SK, Baird WO, Thompson S, et al. The use of non-invasive ventilation at end of life in patients with motor neurone disease: a qualitative exploration of family carer and health professional experiences. Palliat Med 2013, 27:516-523.
50. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73:1218-1226. the Quality Standards Subcommittee of the American Academy of Neurology.
51. Radunovic A, Annane D, Jewitt K, Mustfa N Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2009, 4. CD004427.
52. Miller RG Examining the evidence about treatment in ALS/MND. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:3-7.
53. Oliver D Ventilation in motor neuron disease: difficult decisions in difficult circumstances. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:6-8.
54. Motor neurone disease: the use of non-invasive ventilation in the management of motor neurone disease (NICE clinical guideline 105) 2010, National Institute for Health and Clinical Excellence, National Institute for Health and Clinical Excellence, London.
55. Bourke SC, Gibson GJ Non-invasive ventilation in ALS: current practice and future role. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:67-71.
56. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006, 5:140-147.
57. Lyall RA, Donaldson N, Fleming T, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001, 57:153-156.
58. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999, 164:82-88.
59. O'Neill CL, Williams TL, Peel ET, et al. Non-invasive ventilation in motor neuron disease: an update of current UK practice. J Neurol Neurosurg Psychiatry 2012, 83:371-376.
60. Chiò A, Calvo A, Moglia C, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry 2012, 83:377-381. the PARALS.
61. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999, 52:1311-1323.
62. Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 2005, 32:808-811.
63. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005, 65:1774-1777.
64. Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997, 127:450-453.
65. Goldblatt D, Greenlaw J Starting and stopping the ventilator for patients with amyotrophic lateral sclerosis. Neurol Clin 1989, 7:789-806.
66. Spataro R, Ficano L, Piccoli F, La Bella V Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci 2011, 304:44-48.
67. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999, 169:118-125.
68. Foley G, Timonen V, Hardiman O Exerting control and adapting to loss in amyotrophic lateral sclerosis. Soc Sci Med 2014, 101:113-119.
69. Foley G, Timonen V, Hardiman O Understanding psycho-social processes underpinning engagement with services in motor neurone disease: a qualitative study. Palliat Med 2014, 28:318-325.
70. Martin NH, Landau S, Janssen A, et al. Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study. Amyotroph Lateral Scler Frontotemporal Degener 2014, 15:376-387.
71. Murphy PL, Albert SM, Weber CM, Del Bene ML, Rowland LP Impact of spirituality and religiousness on outcomes in patients with ALS. Neurology 2000, 55:1581-1584.
72. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005, 25:1025-1031.
73. Albert SM, Whitaker A, Rabkin JG, et al. Medical and supportive care among people with ALS in the months before death or tracheostomy. J Pain Symptom Manage 2009, 38:546-553.
74. Dreyer P, Lorenzen CK, Schou L, Felding M Survival in ALS with home mechanical ventilation non-invasively and invasively: a 15-year cohort study in west Denmark. Amyotroph Lateral Scler Frontotemporal Degener 2014, 15:62-67.
75. Georgoulopoulou E, Fini N, Vinceti M, et al. The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy. Amyotroph Lateral Scler Frontotemporal Degener 2013, 14:338-345.
76. Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 2012, 19:360-375. the EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis.
77. Leone M, Chandra V, Schoenberg BS Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology 1987, 37:1339-1343.
78. Caroscio JT, Mulvihill MN, Sterling R, Abrams B Amyotrophic lateral sclerosis. Its natural history. Neurol Clin 1987, 5:1-8.
79. Hussain J, Adams D, Allgar V, Campbell C Triggers in advanced neurological conditions: prediction and management of the terminal phase. BMJ Support Palliat Care 2014, 4:30-37.
80. Spataro R, Lo Re M, Piccoli T, Piccoli F, La Bella V Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2010, 122:217-223.
81. Kühnlein P, Kübler A, Raubold S, et al. Palliative care and circumstances of dying in German ALS patients using non-invasive ventilation. Amyotroph Lateral Scler 2008, 9:91-98.
82. Neudert C, Oliver D, Wasner M, Borasio GD The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001, 248:612-616.
83. Mandler RN, Anderson FA, Miller RG, Clawson L, Cudkowicz M, Del Bene M The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:203-208. the ALS C.A.R.E. Study Group.
84. Higginson IJ, Sen-Gupta GJ Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med 2000, 3:287-300.
85. Gil J, Funalot B, Verschueren A, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol 2008, 15:1245-1251.
86. Veldink JH, Wokke JH, van der Wal G, Vianney de Jong JM, van den Berg LH Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. N Engl J Med 2002, 346:1638-1644.
87. Stutzki R, Weber M, Reiter-Theil S, Simmen U, Borasio GD, Jox RJ Attitudes towards hastened death in ALS: a prospective study of patients and family caregivers. Amyotroph Lateral Scler Frontotemporal Degen 2014, 15:68-76.
88. Maessen M, Veldink JH, Onwuteaka-Philipsen BD, et al. Trends and determinants of end-of-life practices in ALS in the Netherlands. Neurology 2009, 73:954-961.
89. Albert SM, Rabkin JG, Del Bene ML, et al. Wish to die in end-stage ALS. Neurology 2005, 65:68-74.
90. Ganzini L, Silveira MJ, Johnston WS Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington. J Pain Symptom Manage 2002, 24:312-317.
91. Maessen M, Veldink JH, van den Berg LH, Schouten HJ, van der Wal G, Onwuteaka-Philipsen BD Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients. J Neurol 2010, 257:1192-1198.
92. Hedberg K, Hopkins D, Kohn M Five years of legal physician-assisted suicide in Oregon. N Engl J Med 2003, 348:961-964.
93. Stutzki R, Schneider U, Reiter-Theil S, Weber M Attitudes towards assisted suicide and life-prolonging measures in Swiss ALS patients and their caregivers. Front Psychol 2012, 3:443.
94. Jox R, Haarmann-Doetkotte S, Wasner M, Borasio GD The wish to hasten death among ALS patients in a palliative care program. Aktuelle Neurologie 2007, 34:v200.
95. Bascom PB, Tolle SW Responding to requests for physician-assisted suicide: "These are uncharted waters for both of us...". JAMA 2002, 288:91-98.
96. Berger JT Moral distress in medical education and training. J Gen Intern Med 2014, 29:395-398.